Albain KS, et al. Case-Series Study in Ever- and Never-Smoking Females and Males with NSCLC: Exposures, Tumor Factors, Biology and Survival (SWOG S0424). IASLC 2018, abstract OA06.01.
Europese goedkeuring pembrolizumab bij NSCLC met tumor-PD-L1 expressie ≥ 50%
feb 2017 | Longoncologie